Kohler S - Search Results

1

Weaning and extubation failure in myasthenic crisis: a multicenter analysis.

Neumann B, Angstwurm K, Dohmen C, Mergenthaler P, Kohler S, Schönenberger S, Lee DH, Gerner ST, Huttner HB, Thieme A, Steinbrecher A, Dunkel J, Roth C, Schneider H, Reichmann H, Fuhrer H, Kleiter I, Schneider-Gold C, Alberty A, Zinke J, Schroeter M, Linker R, Meisel A, Bösel J, Stetefeld HR; Initiative of German NeuroIntensive Trial Engagement (IGNITE). Neumann B, et al. Among authors: kohler s. J Neurol. 2024 Jan;271(1):564-574. doi: 10.1007/s00415-023-12016-2. Epub 2023 Nov 3. J Neurol. 2024. PMID: 37923937

2

Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP.

Klehmet J, Goehler J, Ulm L, Kohler S, Meisel C, Meisel A, Harms H. Klehmet J, et al. Among authors: kohler s. J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):686-91. doi: 10.1136/jnnp-2014-307708. Epub 2014 Jul 29. J Neurol Neurosurg Psychiatry. 2015. PMID: 25074566

3

Impact of myasthenia gravis on family planning: How do women with myasthenia gravis decide and why?

Ohlraun S, Hoffmann S, Klehmet J, Kohler S, Grittner U, Schneider A, Heuschmann PU, Meisel A. Ohlraun S, et al. Among authors: kohler s. Muscle Nerve. 2015 Sep;52(3):371-9. doi: 10.1002/mus.24556. Epub 2015 Jun 18. Muscle Nerve. 2015. PMID: 25557017

4

IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis.

Schaffert H, Pelz A, Saxena A, Losen M, Meisel A, Thiel A, Kohler S. Schaffert H, et al. Among authors: kohler s. Eur J Immunol. 2015 May;45(5):1339-47. doi: 10.1002/eji.201445064. Epub 2015 Mar 20. Eur J Immunol. 2015. PMID: 25676041 Free article.

5

Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.

Hoffmann S, Siedler J, Brandt AU, Piper SK, Kohler S, Sass C, Paul F, Reilmann R, Meisel A. Hoffmann S, et al. Among authors: kohler s. BMC Neurol. 2015 Dec 23;15:265. doi: 10.1186/s12883-015-0517-8. BMC Neurol. 2015. PMID: 26701600 Free PMC article.

6

Myasthenia gravis: subgroup classifications.

Kohler S, Losen M, Alexander T, Hiepe F, Meisel A. Kohler S, et al. Lancet Neurol. 2016 Apr;15(4):356-7. doi: 10.1016/S1474-4422(16)00033-8. Lancet Neurol. 2016. PMID: 26971655 No abstract available.

7

Fatigue in myasthenia gravis: risk factors and impact on quality of life.

Hoffmann S, Ramm J, Grittner U, Kohler S, Siedler J, Meisel A. Hoffmann S, et al. Among authors: kohler s. Brain Behav. 2016 Aug 2;6(10):e00538. doi: 10.1002/brb3.538. eCollection 2016 Oct. Brain Behav. 2016. PMID: 27781147 Free PMC article.

8

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis.

Scheibe F, Prüss H, Mengel AM, Kohler S, Nümann A, Köhnlein M, Ruprecht K, Alexander T, Hiepe F, Meisel A. Scheibe F, et al. Among authors: kohler s. Neurology. 2017 Jan 24;88(4):366-370. doi: 10.1212/WNL.0000000000003536. Epub 2016 Dec 21. Neurology. 2017. PMID: 28003505

9

CD4⁺ FoxP3⁺ T regulatory cell subsets in myasthenia gravis patients.

Kohler S, Keil TOP, Hoffmann S, Swierzy M, Ismail M, Rückert JC, Alexander T, Meisel A. Kohler S, et al. Clin Immunol. 2017 Jun;179:40-46. doi: 10.1016/j.clim.2017.03.003. Epub 2017 Mar 9. Clin Immunol. 2017. PMID: 28286113

10

S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset.

Pelz A, Schaffert H, Diallo R, Hiepe F, Meisel A, Kohler S. Pelz A, et al. Among authors: kohler s. Eur J Immunol. 2018 Mar;48(3):498-508. doi: 10.1002/eji.201747187. Epub 2017 Dec 19. Eur J Immunol. 2018. PMID: 29205338 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,245 results

Search Page